$16 million in federal funding to support new genomics research in health, agriculture and the environment
As Canada addresses ongoing challenges posed by the COVID-19 pandemic and charts a course for economic recovery, harnessing the game-changing potential of genomics can deliver homegrown solutions and help protect and improve Canadian lives.
Drs. Elizabeth Douville (Chair of the Board of Directors) and Rob Annan (President and CEO) are pleased to announce the appointment of Dr. Bonnie Schmidt and Mr. Andrew Stephens to Genome Canada’s Board of Directors for two-year terms. Dr. Douville and existing Board members Mr. Eric Cook and Dr. Jacques Simoneau were reappointed for additional two-year terms.
Genome Canada is pleased to welcome Dr. Catalina Lopez-Correa as Executive Director, Canadian COVID Genomics Network (CanCOGeN), effective June 22, 2020.
Projects include machine learning research and applications to identify potential treatments, to support public health measures such as social distancing, and to better understand the viral transmission of COVID-19.
Fourteen new AI research projects will be launched to address the COVID-19 outbreak through CIFAR’s AI and COVID-19 Catalyst Grants initiative.
COG-UK and CanCOGeN are working together to share knowledge and protocols
New Canadian network will undertake viral and host genome sequencing to improve patient outcomes
Genome Canada today launched another rapid response funding opportunity to invest in research with real potential to address near-term challenges related to the COVID-19 pandemic.
Genome Canada is pleased to welcome Pari Johnston as Vice-President, Policy and Public Affairs, effective March 23, 2020.
In this role, Pari will provide expertise and leadership that will shape and support the strategic direction of Genome Canada, while raising awareness of the organization and its vision with key stakeholders.
Stemming the spread of COVID-19
Dear friends and colleagues,
$250,000 in research funds designated for genomics-based approach
Genome Canada announced $250,000 in funding for a genomics-based project selected through the Canadian 2019 Novel Coronavirus (COVID-19) Rapid Research Funding Opportunity.
